Federal contract award
36C26323F0091
EIA/IFA REAGENT CONTRACT FOR THE MINNEAPOLIS VAMC
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Veterans Affairs |
| Office | NETWORK CONTRACT OFFICE 23 (36C263) |
| NAICS | 334516 — Analytical Laboratory Instrument Manufacturing |
| PSC | 6550 — In Vitro Diagnostic Substances, Reagents, Test Kits and Sets |
| Parent award / vehicle | GS07F5934R |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $192.1K |
| Current contract value | $192.1K |
| Potential contract value / ceiling | $253.3K |
| Start date | Oct 1, 2023 |
| Current end date | Sep 30, 2027 |
| Potential end date | Sep 30, 2028 |
| Latest award activity | Oct 1, 2026 |
| Source loaded | Oct 17, 2026 |
Funding and modification history
Showing the latest 12 of 12 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Oct 1, 2026 | P00011 | $58.7K | EIA/IFA REAGENT CONTRACT FOR THE MINNEAPOLIS VAMC. ADDING OY3 FUNDS |
| Jun 15, 2026 | P00010 | $-675 | EIA/IFA REAGENT CONTRACT FOR THE MINNEAPOLIS VAMC. 2004, 2005, 3004 AND 3005 PRICE DECREASES. |
| May 7, 2026 | P00009 | $14.7K | EIA/IFA REAGENT CONTRACT FOR THE MINNEAPOLIS VAMC. OY2-4 INCREASE AND EXERCISING OY3 (WITHOUT FUNDING, TO BE ADDED LATER). |
| Nov 4, 2025 | P00008 | $-462 | EIA/IFA REAGENT CONTRACT FOR THE MINNEAPOLIS VAMC. OY1 DEOB |
| Oct 1, 2025 | P00007 | $42.6K | EIA/IFA REAGENT CONTRACT FOR THE MINNEAPOLIS VAMC. ADDING FY 26 FUNDS. |
| May 16, 2025 | P00006 | $0 | EIA/IFA REAGENT CONTRACT FOR THE MINNEAPOLIS VAMC. EXERCISING OY2, FUNDING TO BE ADDED 10/01/2025. |
| May 12, 2025 | P00005 | $-2.4K | EIA/IFA REAGENT CONTRACT FOR THE MINNEAPOLIS VAMC. REDUCTION IN QUANTITY OF LINE ITEMS 1002, 2002, 3002 AND 4002. ADDITION OF BIO-RAD ANTI-DSDNA EIA KIT (SINGLE CALIBRATOR) #96DS TO THIS CONTRACT AS LINE ITEMS 1011, 2011, 3011, 4011. |
| Oct 1, 2024 | P00004 | $47.5K | EIA/IFA REAGENT CONTRACT FOR THE MINNEAPOLIS VAMC. ADDING OY1 FUNDS. |
| Aug 22, 2024 | P00003 | $0 | EIA/IFA REAGENT CONTRACT FOR THE MINNEAPOLIS VAMC. INCREASING LINE ITEMS 1005, 2005, 3005, 4005 AND REDUCING LINE ITEMS 1006, 2006, 3006 AND 4006 TO 0. EXERCISING OY1. |
| Apr 30, 2024 | P00002 | $-13.3K | EIA/IFA REAGENT CONTRACT FOR THE MINNEAPOLIS VAMC, QUANTITY DECREASE MOD |
| Oct 24, 2023 | P00001 | $0 | EIA/IFA REAGENT CONTRACT FOR THE MINNEAPOLIS VAMC, CORRECTIVE DECREASE DUE TO ROUNDING ERROR |
| Jul 25, 2023 | 0 | $45.5K | EIA/IFA REAGENT CONTRACT FOR THE MINNEAPOLIS VAMC |
Estimated positioning window
Sep 30, 2027 – Mar 30, 2028
65/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 65/100. Available recorded signals: 60 points.
- Contract end 2028-09-30 (706 days from calculation)
- +25 points
- 59 historical awards in this buyer and category group
- +15 points
- 12 recorded award transactions
- +10 points
- Latest award action: 2026-10-01
- +5 points
- Parent award identifier recorded
- +5 points
- Solicitation identifier recorded
- +0 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.